You just read:

TreatmentTrends®: Multiple Sclerosis Study Uncovers Early Impact of Gilenya on Perceptions and Anticipated Use of Products Within the MS Market

News provided by

BioTrends Research Group, Inc.

Dec 01, 2010, 09:00 EST